Zoetis CEO: AI Boosts 'Resilient' Animal Health Business

Zoetis CEO Kristin Peck highlighted AI’s transformative role in animal health during a Bloomberg interview, emphasizing its potential to accelerate diagnostics, drug development, and predictive care in veterinary medicine. The animal health industry remains "incredibly resilient," Peck noted, citing steady demand driven by global protein consumption and pet ownership growth, even amid economic fluctuations. AI tools are optimizing Zoetis’ R&D pipeline, reducing costs and time for vaccine and treatment development by analyzing vast datasets for patterns humans might miss. Peck underscored AI’s broader healthcare impact, comparing its disruptive potential in veterinary medicine to advancements in human health, like precision medicine and early disease detection. The CEO’s remarks align with Zoetis’ strategic push to integrate AI across operations, signaling a shift toward tech-driven innovation in the $50B+ global animal health market.